Your browser is no longer supported. Please, upgrade your browser.
Settings
ABT Abbott Laboratories daily Stock Chart
ABT [NYSE]
Abbott Laboratories
IndexS&P 500 P/E80.66 EPS (ttm)0.65 Insider Own0.50% Shs Outstand1.74B Perf Week1.45%
Market Cap91.39B Forward P/E18.88 EPS next Y2.78 Insider Trans-4.65% Shs Float1.72B Perf Month5.78%
Income1.06B PEG7.16 EPS next Q0.65 Inst Own74.20% Short Float0.94% Perf Quarter6.99%
Sales23.61B P/S3.87 EPS this Y-58.60% Inst Trans1.03% Short Ratio3.13 Perf Half Y17.39%
Book/sh18.16 P/B2.89 EPS next Y11.69% ROA2.00% Target Price54.94 Perf Year24.37%
Cash/sh5.65 P/C9.29 EPS next 5Y11.27% ROE4.50% 52W Range37.38 - 52.60 Perf YTD36.71%
Dividend1.06 P/FCF62.51 EPS past 5Y0.00% ROI6.70% 52W High0.01% Beta1.57
Dividend %2.02% Quick Ratio2.40 Sales past 5Y-0.50% Gross Margin54.20% 52W Low40.73% ATR0.65
Employees75000 Current Ratio2.90 Sales Q/Q24.50% Oper. Margin8.80% RSI (14)63.07 Volatility1.39% 1.21%
OptionableYes Debt/Eq0.76 EPS Q/Q-61.70% Profit Margin5.00% Rel Volume1.55 Prev Close52.51
ShortableYes LT Debt/Eq0.75 EarningsOct 19 BMO Payout145.50% Avg Volume5.17M Price52.60
Recom2.00 SMA202.43% SMA504.82% SMA20015.81% Volume2,136,896 Change0.18%
Aug-17-17Initiated Citigroup Neutral $53
Jun-29-17Resumed Jefferies Buy
Jun-29-17Initiated Guggenheim Buy $58
Jun-21-17Resumed BTIG Research Buy $56
May-16-17Initiated Goldman Neutral $45
Apr-20-17Reiterated Barclays Overweight $50 → $52
Mar-01-17Reiterated RBC Capital Mkts Outperform $46 → $50
Jan-26-17Reiterated RBC Capital Mkts Outperform $48 → $46
Jul-21-16Reiterated Barclays Overweight $48 → $50
Jun-21-16Upgrade Edward Jones Hold → Buy
Apr-11-16Reiterated RBC Capital Mkts Outperform $45 → $48
Jan-04-16Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-07-15Upgrade Jefferies Hold → Buy
Nov-13-15Downgrade Goldman Buy → Neutral
Oct-09-15Reiterated RBC Capital Mkts Outperform $55 → $51
Oct-07-15Upgrade Barclays Equal Weight → Overweight $55 → $52
Jul-23-15Reiterated Stifel Buy $53 → $58
Jul-23-15Reiterated RBC Capital Mkts Outperform $51 → $55
Jul-23-15Reiterated Barclays Equal Weight $53 → $55
Apr-23-15Reiterated Stifel Buy $52 → $53
Sep-22-17 03:30PM  Top Stock Reports for Caterpillar, Texas Instruments & Alphabet Zacks
09:35AM  Here's Why You Should Add Abbott (ABT) to Your Portfolio Now Zacks
08:00AM  Abbott Secures FDA Approval for MRI-Compatibility for the Company's Ellipse ICD PR Newswire
Sep-21-17 08:01AM  See what the IHS Markit Score report has to say about Abbott Laboratories. Markit
Sep-20-17 09:00AM  Abbott Hosts Conference Call for Third-Quarter Earnings PR Newswire
08:01AM  See what the IHS Markit Score report has to say about Abbott Laboratories. Markit
Sep-19-17 08:01AM  See what the IHS Markit Score report has to say about Abbott Laboratories. Markit
Sep-18-17 08:01AM  See what the IHS Markit Score report has to say about Abbott Laboratories. Markit
08:00AM  Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. PR Newswire
07:39AM  Abbott Laboratories 375th Consecutive Quarterly Dividend Market Realist
Sep-15-17 12:06PM  The Latest Analyst Recommendations for Abbott Laboratories Market Realist
10:41AM  Abbott Gets UK Reimbursement Approval for Freestyle Libre Market Realist
08:46AM  Abbotts Amplatzer Device Affirms Reduced Recurrent Stroke Rates Market Realist
Sep-14-17 12:28PM  Abbott Declares 375th Consecutive Quarterly Dividend PR Newswire
10:31AM  How Safe Is Abbott Labs' Dividend? Motley Fool
10:01AM  Abbott's (ABT) FreeStyle Libre Gets UK Reimbursement Nod Zacks
08:01AM  See what the IHS Markit Score report has to say about Abbott Laboratories. Markit
Sep-13-17 08:01AM  See what the IHS Markit Score report has to say about Abbott Laboratories. Markit
07:00AM  FreeStyle® Libre Flash Glucose Monitoring Technology Gains Reimbursement Approval from the United Kingdom's National Health Service PR Newswire
Sep-12-17 10:31AM  3 Big Stock Charts for Tuesday: Abbott Laboratories (ABT), Aetna Inc (AET) and Boston Scientific Corporation (BSX) InvestorPlace
08:01AM  See what the IHS Markit Score report has to say about Abbott Laboratories. Markit
Sep-11-17 10:06AM  See what the IHS Markit Score report has to say about Abbott Laboratories. Markit
Sep-08-17 04:08PM  4 Top MedTech Stocks for Dividend Investors in 2017 Zacks
10:21AM  See what the IHS Markit Score report has to say about Abbott Laboratories. Markit
Sep-07-17 11:54AM  ETFs with exposure to Abbott Laboratories : September 7, 2017 Capital Cube
11:49AM  Abbott Named Industry Leader for Responsible and Sustainable Business for Five Consecutive Years on the Dow Jones Sustainability Index (DJSI) PR Newswire
10:19AM  Abbott (ABT) Hits a 52-Week High: What's Driving the Stock? Zacks
Sep-06-17 12:30PM  Forget Abbott, Buy These 4 High-Growth MedTech Stocks Instead Zacks
Sep-05-17 02:06PM  Abbott Laboratories :ABT-US: Earnings Analysis: Q2, 2017 By the Numbers : September 5, 2017 Capital Cube
10:12AM  Walmart Is One of 63 Companies Contributing Massively to Aid Harvey Relief TheStreet.com
Sep-01-17 09:22AM  Abbott's (ABT) FreeStyle Libre Gets Japan Reimbursement Nod Zacks
08:29AM  Abbott's AMPLATZER Pivotal Study to Strengthen Vascular Arm Zacks
08:00AM  Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. PR Newswire
Aug-31-17 09:00AM  Revolutionary Glucose Monitoring Technology FreeStyle® Libre Now Reimbursed Across Japan PR Newswire
Aug-30-17 11:55AM  Abbott initiates ground-breaking U.S. pivotal study of AMPLATZER device to correct common congenital heart defect in newborns PR Newswire
09:43AM  Abbott Updates Pacemaker, Defibrillator Software to Protect Against Hacking TheStreet.com
Aug-29-17 06:39PM  Abbott Releases New Software Updates for Pacemakers The Wall Street Journal
04:14PM  Analysts Recommendations for Pfizer in August 2017 Market Realist
03:02PM  Abbott and the Abbott Fund Donate $1 Million to Support Hurricane Harvey Relief Efforts PR Newswire
02:01PM  Abbott releases new round of cyber updates for St. Jude pacemakers Reuters
12:44PM  Abbott releases new round of cyber updates for St. Jude pacemakers Reuters
09:26AM  Abbott's (ABT) FDA Nod for LVAD Boosts Medical Devices Arm Zacks
Aug-28-17 09:00AM  Abbott Introduces HeartMate 3 Left Ventricular Assist System - the Latest Milestone In Therapy For Advanced Heart Failure Patients PR Newswire
Aug-23-17 05:08PM  Abbott Laboratories Value Analysis (NYSE:ABT) : August 23, 2017 Capital Cube
02:10PM  Abbott Laboratories : ABT-US: Dividend Analysis : July 14th, 2017 (record date) : By the numbers : August 23, 2017 Capital Cube
09:02AM  Abbott Laboratories breached its 50 day moving average in a Bullish Manner : ABT-US : August 23, 2017 Capital Cube
Aug-22-17 08:01AM  See what the IHS Markit Score report has to say about Abbott Laboratories. Markit
Aug-21-17 03:25AM  Why Is Abbott Laboratories (ABT) Down 3.1% Since the Last Earnings Report? Zacks
Aug-16-17 09:52AM  Abbott-North West London Pathology Expand in Diagnostics Zacks
Aug-15-17 08:00AM  North West London Pathology and Abbott Partner for Diagnostics Products and Services, including Alinity, in Three NHS Trusts PR Newswire
Aug-14-17 01:51PM  Keeley All Cap Value Fund 2nd Quarter Shareholder Commentary GuruFocus.com
10:37AM  Pfizers Major Growth Drivers in 2Q17 Market Realist
08:01AM  See what the IHS Markit Score report has to say about Abbott Laboratories. Markit
08:00AM  Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. PR Newswire
07:30AM  [$$] Investment in Heart Disease Treatments Slips in First Half The Wall Street Journal
Aug-12-17 08:00AM  See what the IHS Markit Score report has to say about Abbott Laboratories. Markit
Aug-11-17 10:30PM  Edited Transcript of ABT earnings conference call or presentation 20-Jul-17 1:00pm GMT Thomson Reuters StreetEvents
10:16AM  Abbott Laboratories breached its 50 day moving average in a Bearish Manner : ABT-US : August 11, 2017 Capital Cube
08:00AM  See what the IHS Markit Score report has to say about Abbott Laboratories. Markit
Aug-10-17 09:00AM  The Cost of Malnutrition: Study Shows Nutrition Program Could Save Hospitals up to $3,800 per Patient PR Newswire
08:00AM  IHS Markit Score Update: Drop in demand for ETFs holding Abbott Laboratories is a negative sign for its shares Markit
Aug-09-17 08:00AM  See what the IHS Markit Score report has to say about Abbott Laboratories. Markit
Aug-07-17 11:53AM  Siemens to update medical scanner software to deal with security bugs Reuters
Aug-02-17 08:43AM  No more freebies? India plans crackdown on marketing by drugmakers Reuters
06:07AM  No more freebies: India plans crackdown on marketing by drugmakers Reuters
Aug-01-17 11:16AM  Healthcare Stocks: Calm After The Storm? Barrons.com
Jul-26-17 09:30AM  The Zacks Analyst Blog Highlights: Oracle, Pfizer, Abbott, Alphabet and Schlumberger Zacks
09:08AM  Analysts Raise Recommendations on Abbott Stock after 2Q17 Market Realist
07:41AM  Abbott Laboratories Updated Guidance for 2017 Market Realist
Jul-25-17 02:06PM  What Were Abbotts Key Growth Drivers for 2Q17? Market Realist
12:36PM  Abbott Laboratories 2Q17 Results: Which Segment Fared Best? Market Realist
11:01AM  Strong 2Q17 Results Trigger Rise in Abbott Stock Market Realist
Jul-24-17 03:25PM  Abbott deal will cost Alere three business units and untold employees American City Business Journals
07:38AM  Abiomed Expects to Expand Its Presence in This Space Market Realist
Jul-21-17 02:47PM  Abiomed Impella Quality Program Will Boost Demand in Fiscal 2018 Market Realist
02:35PM  Behind the Major Drivers of JNJs Medical Device Growth Market Realist
10:40AM  Inside Abiomeds Profit Margin Expectations for Fiscal 2018 Market Realist
09:51AM  Company News for July 21, 2017 Zacks
08:00AM  Today's Research Reports on Stocks to Watch: Abbott Laboratories and Pfizer Inc. Accesswire
12:35AM  Abbott tops Street 2Q forecasts Associated Press
Jul-20-17 06:02PM  LabCorp (LH) Q2 Earnings: Is Disappointment in the Cards? Zacks
05:47PM  Abiomed in 2017: The Analysts View Market Realist
04:09PM  Markets Right Now: US struggle to a mixed finish Associated Press
04:09PM  Markets Right Now: US struggle to a mixed finish Associated Press
04:03PM  Abbott Zeros In On A 2-Year High After Topping Q2 Sales, Profits Investor's Business Daily
01:05PM  US STOCKS-S&P, Dow flat as retailers weigh; Nasdaq edges higher Reuters
12:35PM  Abbott profit forecast gets a lift from St. Jude integration Reuters
12:34PM  Abbott Labs (ABT) Beats on Q2 Earnings and Sales, View Up Zacks
12:00PM  Abbott CEO: Another Alere-Related Divestiture Coming Soon TheStreet.com
11:25AM  US STOCKS-Wall St flat as consumer stocks, weak earnings weigh Reuters
10:10AM  US STOCKS-Wall St flat as earnings from some big names disappoint Reuters
09:30AM  Abbott (ABT) Tops Earnings Estimates in Q2, Misses on Sales Zacks
08:49AM  US STOCKS-Wall St set to open higher on earnings optimism Reuters
07:56AM  Abbott's quarterly profit halves as costs soar Reuters
07:45AM  Abbott Reports Second-Quarter 2017 Results PR Newswire
Jul-19-17 03:56PM  Alere, St. Jude Deals in Focus as Abbott Releases Q2 Earnings TheStreet.com
09:52AM  Medical Product Stocks' Earnings on Jul 20: ABT, ISRG & More Zacks
Jul-18-17 05:21PM  Quidel Diversifies With Alere's Triage Assets TheStreet.com
02:27PM  Abbott's Tarnished Deal Sparkles for Another Bloomberg
Jul-17-17 05:29PM  Chartmaster says these are the 3 names you should buy on ... CNBC Videos
Abbott Laboratories manufactures and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; cardiovascular and metabolic products; and influenza vaccines, as well as to regulate physiological rhythm of the colon. Its Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments to automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; informatics and automation solutions; and a suite of informatics tools and professional services. The company's Nutritional Products segment provides pediatric and adult nutritional products. Its Vascular Products segment offers coronary, endovascular, vessel closure, and structural heart devices to treat vascular disease. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in North Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fussell Stephen RExecutive Vice PresidentAug 16Option Exercise25.56196,5505,023,939378,688Aug 18 05:10 PM
Fussell Stephen RExecutive Vice PresidentAug 16Sale49.50196,5509,729,225182,138Aug 18 05:10 PM
LIDDY EDWARD MDirectorAug 14Buy48.961,18558,01222,967Aug 22 05:04 PM
STARKS DANIEL JDirectorAug 02Option Exercise31.59504,54415,939,1526,943,248Aug 03 05:20 PM
Bracken Sharon JSenior Vice PresidentAug 01Sale49.162,00098,32327,206Aug 03 05:14 PM
Blaser Brian JExecutive Vice PresidentJul 27Sale50.0015,000750,000143,154Jul 28 05:04 PM
ALLEN HUBERT LExecutive Vice PresidentJul 25Option Exercise26.704,600122,808105,479Jul 27 05:03 PM
ALLEN HUBERT LExecutive Vice PresidentJul 25Sale50.794,600233,647100,879Jul 27 05:03 PM
Watkin JaredSenior Vice PresidentJun 15Sale47.9755226,48246,538Jun 16 05:02 PM
Fussell Stephen RExecutive Vice PresidentJun 08Option Exercise25.56196,5505,023,939378,688Jun 09 05:04 PM
Fussell Stephen RExecutive Vice PresidentJun 08Sale46.00196,5509,041,360182,138Jun 09 05:04 PM
BIRD ROGERSenior Vice PresidentApr 27Sale43.825,600245,39351,313Apr 28 05:28 PM
MANNING JOSEPH JSenior Vice PresidentApr 26Option Exercise26.703,20085,43126,224Apr 28 05:27 PM
MANNING JOSEPH JSenior Vice PresidentApr 26Sale43.954,200184,59922,024Apr 28 05:27 PM
Contreras JaimeSenior Vice PresidentMar 31Sale44.6476734,2402,410Apr 04 05:02 PM
YOOR BRIAN BExecutive Vice President & CFOMar 01Sale45.391,72878,43463,425Mar 02 05:19 PM
NATH DEEPAK S.Senior Vice PresidentMar 01Sale45.391,60172,66951,430Mar 02 05:17 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentMar 01Sale45.392,06693,77672,112Mar 02 05:16 PM
Warmuth Michael JExecutive Vice PresidentMar 01Sale45.393,851174,79756,508Mar 02 05:04 PM
Watkin JaredSenior Vice PresidentMar 01Sale45.3997044,02848,511Mar 02 05:12 PM
BIRD ROGERSenior Vice PresidentFeb 28Sale45.021,60172,06956,913Mar 02 05:11 PM
Mason Heather LExecutive Vice PresidentFeb 28Sale45.011,91286,06859,677Mar 02 05:06 PM
Contreras JaimeSenior Vice PresidentFeb 28Sale45.0113,155592,15745,733Mar 02 05:05 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 28Sale45.0185738,569100,879Mar 02 05:15 PM
MANNING JOSEPH JSenior Vice PresidentFeb 28Sale44.9674433,45323,024Mar 02 05:18 PM
Funck Robert EVice President, ControllerFeb 23Option Exercise26.7025,500680,781117,579Feb 24 05:28 PM
Funck Robert EVice President, ControllerFeb 23Sale45.5025,5001,160,25092,079Feb 24 05:28 PM
BIRD ROGERSenior Vice PresidentFeb 22Option Exercise26.6212,903343,53975,767Feb 22 05:59 PM
BIRD ROGERSenior Vice PresidentFeb 22Sale45.0212,903580,93862,864Feb 22 05:59 PM
CAPEK JOHN MExecutive Vice PresidentFeb 21Option Exercise26.7093,4002,493,528382,197Feb 22 05:57 PM
Watkin JaredSenior Vice PresidentFeb 21Sale44.9855524,96551,977Feb 22 05:57 PM
NATH DEEPAK S.Senior Vice PresidentFeb 21Sale44.9831914,34957,333Feb 22 05:34 PM
MANNING JOSEPH JSenior Vice PresidentFeb 21Sale44.981466,56720,146Feb 22 06:18 PM
BIRD ROGERSenior Vice PresidentFeb 21Sale44.9431914,33562,864Feb 22 05:59 PM
CAPEK JOHN MExecutive Vice PresidentFeb 21Sale45.0093,4004,203,000288,797Feb 22 05:57 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 13Option Exercise25.253,40085,83791,857Feb 15 05:04 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 13Sale43.003,400146,20088,457Feb 15 05:04 PM
MANNING JOSEPH JSenior Vice PresidentFeb 03Option Exercise25.253007,57420,792Feb 07 05:02 PM
Mason Heather LExecutive Vice PresidentJan 31Option Exercise25.2535,700901,286100,189Feb 02 05:31 PM
Fussell Stephen RExecutive Vice PresidentJan 31Buy40.7712,200497,394167,167Feb 02 05:32 PM
Mason Heather LExecutive Vice PresidentJan 31Sale40.7735,7001,455,48964,489Feb 02 05:31 PM
Blaser Brian JExecutive Vice PresidentDec 20Buy38.4515,580599,120145,062Dec 21 02:19 PM
Ford Robert BExecutive Vice PresidentDec 14Buy39.0912,775499,34569,542Dec 16 05:07 PM
CAPEK JOHN MExecutive Vice PresidentNov 16Option Exercise24.3822,000536,386274,524Nov 18 05:02 PM
WHITE MILES DChairman and CEONov 10Buy40.6758,2632,369,4483,111,967Nov 14 10:04 AM
WHITE MILES DChairman and CEONov 10Buy40.5389,5783,630,2943,004,943Nov 14 10:03 AM
WHITE MILES DChairman and CEONov 10Buy40.6548,7611,982,0793,053,704Nov 14 10:03 AM
WHITE MILES DChairman and CEONov 10Buy40.5451,8922,103,4552,793,909Nov 14 10:02 AM
WHITE MILES DChairman and CEONov 10Buy40.45121,4564,912,7412,915,365Nov 14 10:02 AM
Blount Sally E.DirectorNov 01Buy39.245,100200,12420,143Nov 02 05:12 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentSep 26Sale41.7181533,99458,976Sep 28 05:05 PM